Getting Started on VANRAFIA
First ETA receptor antagonist in IgAN without a REMS program
Use of VANRAFIA is contraindicated in patients who are pregnant and patients with hypersensitivity. Serious warnings associated with VANRAFIA include embryo-fetal toxicity, hepatotoxicity, fluid retention, and decreased sperm counts. Most common adverse reactions (incidence ≥5%) were peripheral edema and anemia. Please see additional Important Safety Information throughout.
Choose 1 of 2 ways to submit Rx for VANRAFIA
1. SEND Rx DIRECTLY TO 1 OF 2 LIMITED NETWORK SPECIALTY PHARMACIES
Biologics by McKesson
Website: biologics.mckesson.com ↗
Phone: 1-800-850-4306
Fax: 1-800-823-4506
CareMed*
Website: caremedsp.com ↗
Phone: 1-877-227-3405
Fax: 1-877-542-2731
*CareMed is a subsidiary of Onco360®.
2. COMPLETE START FORM WITH NOVARTIS PATIENT SUPPORT™
Working with a specialty pharmacy
Unlike a traditional retail pharmacy, the specialty pharmacy will ship VANRAFIA directly to your patients. Ensure your patient is aware which specialty pharmacy will deliver their medication.
Novartis does not recommend or require the use of any particular pharmacy.
Typical support offered by specialty pharmacies can include the following:
Clinical and educational support
Assistance navigating insurance coverage
Affordability support
Refill reminders
Ongoing communication
Please reach out to the specialty pharmacy to learn more about the support that may be available.
Help your patients start, stay, and save on VANRAFIA. Learn more about Novartis Patient Support
See the resources available for download